150 related articles for article (PubMed ID: 36222892)
1. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
[TBL] [Abstract][Full Text] [Related]
3. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
4. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
[TBL] [Abstract][Full Text] [Related]
5. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
[TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
Liu Z; Pan L; Yan X; Duan X
FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer.
Lu J; Xu Y; Xie W; Tang Y; Zhang H; Wang B; Mao J; Rui T; Jiang P; Zhang W
Cell Death Discov; 2021 Sep; 7(1):255. PubMed ID: 34545072
[TBL] [Abstract][Full Text] [Related]
13. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DLGAP1-AS1 promotes the progression of gastric cancer via miR-515-5p/MARK4 axis.
Li L; Lai Q; Zhang M; Jia J
Braz J Med Biol Res; 2021; 54(8):e10062. PubMed ID: 34037089
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.
Lin J; Shi Z; Yu Z; He Z
Biomed Pharmacother; 2018 Feb; 98():433-439. PubMed ID: 29278853
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCGEM1 promotes colorectal cancer cell proliferation and migration in positive feedback loop through PCGEM1/miR-433-3p/CTCF axis.
Xu W; Wu L; Lu H; Xiang X; Wang F; Li S
Pathol Res Pract; 2022 Sep; 237():154017. PubMed ID: 35872368
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]